Voyager Therapeutics IncNASDAQ:VYGR
- LAST PRICE5.4300
- TODAY'S CHANGE (%)0.0700 (1.3060%)
- Bid / Lots5.4100/ 1
- Ask / Lots5.7000/ 4
- Open / Previous Close5.3500 / 5.3600
- Day Range
- 52 Week Range
- Volume483,366
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VYGR |
|---|---|---|
| 09:32 ET | 9423 | 5.395 |
| 09:33 ET | 1780 | 5.32 |
| 09:35 ET | 5572 | 5.33 |
| 09:37 ET | 23424 | 5.28 |
| 09:39 ET | 120 | 5.3 |
| 09:42 ET | 400 | 5.29 |
| 09:44 ET | 2100 | 5.285 |
| 09:46 ET | 1500 | 5.27 |
| 09:48 ET | 600 | 5.285 |
| 09:50 ET | 946 | 5.3 |
| 09:51 ET | 10057 | 5.31 |
| 09:53 ET | 470 | 5.31 |
| 09:55 ET | 608 | 5.28 |
| 09:57 ET | 209 | 5.3 |
| 10:00 ET | 4200 | 5.26 |
| 10:02 ET | 1685 | 5.27 |
| 10:04 ET | 3700 | 5.24 |
| 10:06 ET | 3316 | 5.22 |
| 10:08 ET | 14242 | 5.2 |
| 10:09 ET | 7371 | 5.21 |
| 10:11 ET | 5251 | 5.23 |
| 10:13 ET | 1747 | 5.23 |
| 10:15 ET | 500 | 5.25 |
| 10:18 ET | 3337 | 5.255 |
| 10:20 ET | 800 | 5.27 |
| 10:22 ET | 100 | 5.27 |
| 10:24 ET | 500 | 5.28 |
| 10:26 ET | 100 | 5.28 |
| 10:27 ET | 1469 | 5.26 |
| 10:29 ET | 3216 | 5.24 |
| 10:31 ET | 1952 | 5.25 |
| 10:33 ET | 719 | 5.26 |
| 10:36 ET | 200 | 5.27 |
| 10:38 ET | 1650 | 5.295 |
| 10:40 ET | 100 | 5.295 |
| 10:42 ET | 444 | 5.28 |
| 10:44 ET | 400 | 5.29 |
| 10:47 ET | 1711 | 5.305 |
| 10:49 ET | 800 | 5.305 |
| 10:51 ET | 600 | 5.33 |
| 10:54 ET | 2500 | 5.375 |
| 10:56 ET | 822 | 5.39 |
| 11:00 ET | 1918 | 5.3807 |
| 11:02 ET | 3075 | 5.38 |
| 11:03 ET | 300 | 5.37 |
| 11:05 ET | 534 | 5.37 |
| 11:07 ET | 4890 | 5.41 |
| 11:09 ET | 3348 | 5.42 |
| 11:12 ET | 350 | 5.42 |
| 11:14 ET | 100 | 5.41 |
| 11:16 ET | 1934 | 5.4403 |
| 11:18 ET | 885 | 5.44 |
| 11:20 ET | 1300 | 5.42 |
| 11:21 ET | 300 | 5.41 |
| 11:23 ET | 400 | 5.41 |
| 11:25 ET | 734 | 5.42 |
| 11:27 ET | 1161 | 5.42 |
| 11:30 ET | 600 | 5.41 |
| 11:32 ET | 200 | 5.41 |
| 11:34 ET | 1502 | 5.41 |
| 11:36 ET | 1301 | 5.43 |
| 11:39 ET | 100 | 5.4 |
| 11:41 ET | 2173 | 5.41 |
| 11:43 ET | 390 | 5.4 |
| 11:45 ET | 500 | 5.41 |
| 11:50 ET | 100 | 5.4 |
| 11:52 ET | 100 | 5.41 |
| 11:54 ET | 1000 | 5.41 |
| 11:56 ET | 300 | 5.415 |
| 11:57 ET | 100 | 5.415 |
| 11:59 ET | 300 | 5.42 |
| 12:06 ET | 300 | 5.41 |
| 12:10 ET | 1105 | 5.41 |
| 12:12 ET | 300 | 5.41 |
| 12:15 ET | 350 | 5.41 |
| 12:19 ET | 1050 | 5.42 |
| 12:21 ET | 100 | 5.41 |
| 12:24 ET | 1000 | 5.42 |
| 12:26 ET | 300 | 5.42 |
| 12:28 ET | 264 | 5.42 |
| 12:30 ET | 483 | 5.42 |
| 12:32 ET | 3581 | 5.44 |
| 12:33 ET | 300 | 5.43 |
| 12:35 ET | 2722 | 5.4 |
| 12:37 ET | 300 | 5.405 |
| 12:39 ET | 1300 | 5.41 |
| 12:42 ET | 400 | 5.41 |
| 12:44 ET | 310 | 5.42 |
| 12:46 ET | 1844 | 5.4217 |
| 12:48 ET | 300 | 5.44 |
| 12:50 ET | 2600 | 5.43 |
| 12:51 ET | 100 | 5.425 |
| 12:53 ET | 6368 | 5.46 |
| 12:55 ET | 600 | 5.47 |
| 12:57 ET | 1400 | 5.49 |
| 01:00 ET | 1244 | 5.485 |
| 01:02 ET | 3281 | 5.47 |
| 01:04 ET | 1405 | 5.48 |
| 01:06 ET | 2500 | 5.47 |
| 01:08 ET | 1702 | 5.465 |
| 01:11 ET | 1000 | 5.47 |
| 01:13 ET | 200 | 5.46 |
| 01:15 ET | 200 | 5.46 |
| 01:18 ET | 800 | 5.46 |
| 01:20 ET | 183 | 5.46 |
| 01:22 ET | 1500 | 5.46 |
| 01:24 ET | 200 | 5.47 |
| 01:26 ET | 2500 | 5.475 |
| 01:27 ET | 4222 | 5.4799 |
| 01:29 ET | 649 | 5.465 |
| 01:31 ET | 900 | 5.47 |
| 01:33 ET | 200 | 5.47 |
| 01:36 ET | 100 | 5.47 |
| 01:38 ET | 5802 | 5.47 |
| 01:40 ET | 800 | 5.47 |
| 01:42 ET | 100 | 5.46 |
| 01:44 ET | 1812 | 5.46 |
| 01:45 ET | 125 | 5.4681 |
| 01:47 ET | 1550 | 5.455 |
| 01:49 ET | 1600 | 5.455 |
| 01:51 ET | 400 | 5.455 |
| 01:54 ET | 9163 | 5.455 |
| 01:56 ET | 300 | 5.455 |
| 01:58 ET | 400 | 5.45 |
| 02:02 ET | 100 | 5.45 |
| 02:03 ET | 200 | 5.45 |
| 02:05 ET | 100 | 5.46 |
| 02:07 ET | 100 | 5.455 |
| 02:09 ET | 800 | 5.451 |
| 02:12 ET | 5002 | 5.45 |
| 02:14 ET | 20505 | 5.42 |
| 02:16 ET | 2926 | 5.435 |
| 02:18 ET | 500 | 5.425 |
| 02:20 ET | 100 | 5.425 |
| 02:21 ET | 400 | 5.41 |
| 02:23 ET | 800 | 5.42 |
| 02:25 ET | 700 | 5.435 |
| 02:27 ET | 1205 | 5.44 |
| 02:30 ET | 200 | 5.435 |
| 02:32 ET | 100 | 5.435 |
| 02:34 ET | 1600 | 5.445 |
| 02:36 ET | 800 | 5.445 |
| 02:38 ET | 300 | 5.445 |
| 02:41 ET | 2300 | 5.445 |
| 02:43 ET | 200 | 5.445 |
| 02:45 ET | 200 | 5.445 |
| 02:48 ET | 100 | 5.445 |
| 02:50 ET | 2518 | 5.43 |
| 02:52 ET | 2791 | 5.445 |
| 02:54 ET | 200 | 5.445 |
| 02:56 ET | 316 | 5.445 |
| 02:57 ET | 700 | 5.435 |
| 02:59 ET | 1000 | 5.43 |
| 03:01 ET | 100 | 5.425 |
| 03:03 ET | 300 | 5.43 |
| 03:06 ET | 2658 | 5.41 |
| 03:08 ET | 3543 | 5.43 |
| 03:10 ET | 200 | 5.43 |
| 03:12 ET | 400 | 5.43 |
| 03:14 ET | 1200 | 5.43 |
| 03:15 ET | 500 | 5.43 |
| 03:17 ET | 3443 | 5.46 |
| 03:19 ET | 200 | 5.46 |
| 03:21 ET | 400 | 5.46 |
| 03:24 ET | 100 | 5.46 |
| 03:26 ET | 400 | 5.45 |
| 03:28 ET | 200 | 5.46 |
| 03:30 ET | 1200 | 5.45 |
| 03:32 ET | 420 | 5.4577 |
| 03:33 ET | 300 | 5.44 |
| 03:35 ET | 5136 | 5.432877 |
| 03:37 ET | 300 | 5.435 |
| 03:39 ET | 4658 | 5.44 |
| 03:42 ET | 300 | 5.44 |
| 03:44 ET | 781 | 5.435 |
| 03:48 ET | 3222 | 5.45 |
| 03:50 ET | 1034 | 5.435 |
| 03:51 ET | 16560 | 5.42 |
| 03:53 ET | 1607 | 5.425 |
| 03:55 ET | 9549 | 5.41 |
| 03:57 ET | 2007 | 5.415 |
| 04:00 ET | 59347 | 5.43 |
Nov 20, 2024
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
DJ Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:24AM ET on Thursday Nov 14, 2024 by Dow Jones
11:24AM ET on Thursday Nov 14, 2024 by Dow JonesDJ Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 5:01AM ET on Thursday Nov 14, 2024 by Dow Jones
5:01AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
Voyager Reports Third Quarter 2024 Financial and Operating Results, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Voyager Therapeutics 3Q Loss/Shr 16c >VYGR, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Voyager Therapeutics Inc | 296.1M | 9.2x | --- |
Ginkgo Bioworks Holdings Inc | 378.8M | -0.5x | --- |
Revance Therapeutics Inc | 402.8M | -2.0x | --- |
Coherus BioSciences Inc | 126.7M | -12.3x | --- |
Vanda Pharmaceuticals Inc | 288.0M | -17.5x | -37.98% |
Amarin Corporation PLC | 215.9M | -5.5x | --- |
Company Information
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs, all of which are in preclinical development, include Anti-Tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy Program, Tau Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program, and others. VY-TAU01 is for the treatment of Alzheimer’s disease. SOD1 Silencing Gene Therapy Program is for the treatment of ALS.
Contact Information
- Headquarters
- 75 Hayden AvenueLEXINGTON, MA, United States 02421
- Phone
- 857-259-5340
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Michael Higgins
- President, Chief Executive Officer, Director
- Alfred Sandrock
- Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
- Nathan Jorgensen
- Chief Operating Officer
- Robin Swartz
- Chief Scientific Officer
- Todd Carter
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $296.1M |
|---|---|
Revenue (TTM) | $163.8M |
Shares Outstanding | 54.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.87 |
EPS | $0.59 |
Book Value | $5.37 |
P/E Ratio | 9.2x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | 9.6x |
Operating Margin | 5.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
